Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6652
Reference
MSAN(2019)16
Name
Medicine Supply Alert Notice: Provera® (medroxyprogesterone acetate) 100mg and 200mg tablets: update
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
Pfizer, sole supplier of Provera® tablets, have advised that resupply of Provera® 100mg tablets is delayed until 13 December 2019; Provera® 200mg tablets are now out of stock until 20 December 2019; and Provera® 400mg tablets are available but cannot support an increase in demand. Unlicensed imports of medroxyprogesterone 100mg tablets remain available.
Contact Name
Contact Email
Contact Address
Created
2019-11-15 00:00:00
Click to go back to homepage